Found 39 matching trials
Vaccine Therapy in Treating Patients With Stage IV Melanoma PHASE1 RATIONALE: Vaccines may make the body build an immune response to kill tumo...
Show More Location
USC/Norris Comprehensive Cancer Center and Hospital
Learn More & Join Trial
Vaccine Therapy in Treating Patients With Melanoma PHASE2 RATIONALE: Vaccines may make the body build an immune response to kill tumo...
Show More Location
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support
Learn More & Join Trial
A Study of RO7293583 in Participants With Unresectable Metastatic Tyrosinase Related Protein 1 (TYRP1)-Positive Melanomas PHASE1 This is a first-in-human, multi-center clinical study to determine the safe...
Show More Location
Dana Farber Cancer Institute
Learn More & Join Trial
Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma PHASE1 RATIONALE: Vaccines may make the body build an immune response to kill tumo...
Show More Location
Memorial Sloan-Kettering Cancer Center
Learn More & Join Trial
Vaccine Therapy Plus Immune Adjuvants in Treating Patients With Advanced Melanoma PHASE2 RATIONALE: Vaccines made from peptides that are found on melanoma cells may...
Show More Location
Memorial Sloan-Kettering Cancer Center
Learn More & Join Trial
Vaccine Therapy in Treating Patients With Recurrent or Refractory Metastatic Melanoma PHASE2 RATIONALE: Vaccines may make the body build an immune response to kill tumo...
Show More Learn More & Join Trial
Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV Melanoma PHASE2 RATIONALE: Vaccines made from melanoma cells may make the body build an imm...
Show More Location
USC/Norris Comprehensive Cancer Center and Hospital
Learn More & Join Trial
Injection Of AJCC Stage IIB, IIC, III And IV Melanoma Patients With A Multi-Epitope Peptide Vaccine Using GM-CSF DNA As An Adjuvant: A Pilot Trial To Assess Safety And Immunity EARLY_PHASE1 This is a pilot trial to investigate the use of GM-CSF DNA as an adjuvant f...
Show More Location
Memorial Sloan-Kettering Cancer Center
Learn More & Join Trial
Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma PHASE2 RATIONALE: Monoclonal antibodies can locate tumor cells and either kill the...
Show More Location
H. Lee Moffitt Cancer Center and Research Institute at University of South Florida
Learn More & Join Trial
Immune Responses to Autologous Langerhans-type Dendritic Cells Electroporated With mRNA Encoding a Tumor-associated Antigen in Patients With Malignancy: A Single-arm Phase I Trial in Melanoma PHASE1 This study is being done to see if the investigators can help the immune sy...
Show More Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial